| [1] |
GBD 2021 STROKE RISK FACTOR COLLABORATORS. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet Neurol, 2024, 23(10): 973-1003.
|
| [2] |
ZHANG H Y, ZHENG L. Statistical analysis for efficacy of tirofiban combined with ozagrel in the treatment of progressive cerebral infarction patients out of thrombolytic therapy time window[J]. Clinics, 2021, 76: e2728.
|
| [3] |
MAO Z G, TIAN L Y, LIU J, et al. Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy[J]. Phytomedicine, 2022, 101: 154111.
|
| [4] |
YANG S L, XU D K, ZHANG D H, et al. Levofloxacin alleviates blood-brain barrier disruption following cerebral ischemia and reperfusion via directly inhibiting A-FABP[J]. Eur J Pharmacol, 2024, 963: 176275.
|
| [5] |
XIANG T, GUO Q R, JIA L H, et al. Multifunctional hydrogels for the healing of diabetic wounds[J]. Adv Healthc Mater, 2024, 13(1): 2301885.
|
| [6] |
唐佳欣, 耿佳庆, 严彩霞, 等. 姜黄素改善缺氧缺血性脑损伤新生大鼠远期神经行为缺陷的机制[J]. 疑难病杂志, 2024, 23(7): 861-865.
|
| [7] |
陈 尧, 高玺宇, 颜傲寒, 等. 甜菊苷对鱼藤酮诱导的长爪沙鼠神经损伤的影响[J]. 中国兽医学报, 2026, 46(3): 644-649.
|
| [8] |
白凌云, 抗晶晶, 曹 翔. 小胶质细胞糖代谢重编程在中枢神经系统疾病中的研究进展[J]. 中风与神经疾病杂志, 2025, 42(01): 65-69.
|
| [9] |
HERST P M, GRASSO C, BERRIDGE M V. Metabolic reprogramming of mitochondrial respiration in metastatic cancer[J]. Cancer Metastasis Rev, 2018, 37(4): 643-653.
|
| [10] |
HORN P, TACKE F. Metabolic reprogramming in liver fibrosis[J]. Cell Metab, 2024, 36(7): 1439-1455.
|
| [11] |
BRUSCO J, HAAS K. Interactions between mitochondria and the transcription factor myocyte enhancer factor 2 (MEF2) regulate neuronal structural and functional plasticity and metaplasticity[J]. J Physiol, 2015, 593(16): 3471-3481.
|
| [12] |
XU S L, DENG K Q, LU C B, et al. Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects[J]. Metabolism, 2024, 155: 155832.
|
| [13] |
LIANG Y T, CHEN B Q, LIANG D, et al. Pharmacological effects of astragaloside Ⅳ: a review[J]. Molecules, 2023, 28(16): 6118.
|
| [14] |
WANG J Y, PU X Y, ZHUANG H W, et al. Astragaloside Ⅳ alleviates septic myocardial injury through DUSP1-Prohibitin 2 mediated mitochondrial quality control and ER-autophagy[J]. J Adv Res, 2025, 75: 561-580.
|
| [15] |
欧 典, 李艳玲, 刘晓丹, 等. 黄芪甲苷与三七总皂苷配伍冰片改善大鼠脑缺血再灌注后肾脏损伤的研究[J]. 湖南中医药大学学报, 2024, 44(1): 1-8.
|
| [16] |
WANG X J, ZHAO H Y, LIN W Y, et al. Panax notoginseng saponins ameliorate LPS-induced acute lung injury by promoting STAT6-mediated M2-like macrophage polarization[J]. Phytomedicine, 2025, 139: 156513.
|
| [17] |
YU Z, YANG X Y, CAI Y Q, et al. Panax Notoginseng Saponins promotes the meningeal lymphatic system-mediated hematoma absorption in intracerebral hemorrhage[J]. Phytomedicine, 2024, 135: 156149.
|
| [18] |
SEMENZA G L. A compendium of proteins that interact with HIF-1α[J]. Exp Cell Res, 2017, 356(2): 128-135.
|
| [19] |
葛文静. 基于PI3K/AKT信号通路探究益气通脉方对脑缺血再灌注大鼠神经细胞凋亡的作用机制[D]. 郑州: 河南中医药大学, 2023.
|
| [20] |
刘玉莲. 补阳还五汤通过FPR2调控小胶质细胞极化减轻大鼠脑缺血再灌注后炎症损伤[D]. 广州: 广州中医药大学, 2021.
|
| [21] |
彭志锋, 李晨旭, 张继红, 等. 早期跑步运动对局灶性脑缺血再灌注大鼠海马神经损伤的影响[J]. 郑州大学学报(医学版), 2025, 60(6): 813-817.
|
| [22] |
KHANDELWAL P, YAVAGAL D R, SACCO R L. Acute ischemic stroke intervention[J]. J Am Coll Cardiol, 2016, 67(22): 2631-2644.
|
| [23] |
BOHLSON S S, TENNER A J. Complement in the brain: contributions to neuroprotection, neuronal plasticity, and neuroinflammation[J]. Annu Rev Immunol, 2023, 41: 431-452.
|
| [24] |
刘晓丹, 杨筱倩, 唐 三, 等. 冰片对黄芪甲苷和三七总皂苷配伍有效成分在脑缺血/再灌注模型大鼠脑组织分布的影响[J]. 中草药, 2019, 50(7): 1649-1656.
|
| [25] |
XUE J Q, ZHANG Y, ZHANG J H, et al. Astrocyte-derived CCL7 promotes microglia-mediated inflammation following traumatic brain injury[J]. Int Immunopharmacol, 2021, 99: 107975.
|
| [26] |
HASSAMAL S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories[J]. Front Psychiatry, 2023, 14: 1130989.
|
| [27] |
VÁZQUEZ-GONZÁLEZ D, CARREÓN-TRUJILLO S, ALVAREZ-ARELLANO L, et al. A potential role for neuroinflammation in ADHD[M]//Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders. Singapore: Springer Nature Singapore, 2023: 327-356.
|
| [28] |
PERREM L, RATJEN F. Designing clinical trials for anti-inflammatory therapies in cystic fibrosis[J]. Front Pharmacol, 2020, 11: 576293.
|
| [29] |
SPOELSTRA S K, VISSER L, KNEGTERING H. Muscarinic M1 and/or M4 receptor agonists as potential novel treatments for psychoses[J]. Tijdschrift Voor Psychiatr, 2023, 65(9):555-562
|
| [30] |
RUSSO S, KWIATKOWSKI M, GOVORUKHINA N, et al. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites[J]. Front Immunol, 2021, 12: 746151.
|
| [31] |
SHIMAMURA M, HAYASHI H, JU N, et al. R-spondin 3/LGR4 (leucine-rich repeat-containing G protein-coupled receptor 4) axis is a novel inflammatory and neurite outgrowth signaling system in the ischemic brain in mice[J]. Stroke, 2023, 54(6): 1606-1615.
|
| [32] |
ZHOU J M, ZHANG J B, XU F, et al. AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated glycolysis[J]. Mol Med, 2024, 30(1): 133.
|
| [33] |
ZHENG J, CHEN P E, ZHONG J F, et al. HIF-1α in myocardial ischemia-reperfusion injury (Review)[J]. Mol Med Rep, 2021, 23(5): 352.
|
| [34] |
PAN Y T, WU G, CHEN M, et al. Lactate promotes hypoxic granulosa cells’ autophagy by activating the HIF-1α/BNIP3/beclin-1 signaling axis[J]. Genes, 2025, 16(1): 14.
|